Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyMyelomaTeam Member asked a question 💭
Crestview, FL
1 day ago
 · 
Be the first to react
A MyMyelomaTeam Member

Interesting! I had never heard of HyqVia subcutaneous immunoglobulin treatment before and had to look it up. It sounds easier and more effective than getting a 3 hr IVIG infusion and will be asking my doctor about it this winter- thanks!

Gemini AI:
HyqVia is a facilitated subcutaneous immunoglobulin (fSCIG) treatment, meaning it is administered under the skin rather than directly into a vein. While it shares the same core active ingredient—human immunoglobulin antibodies—as IVIG, its formulation and delivery method differ significantly. 

Key Differences Between HyqVia and IVIG
1. The Hyaluronidase Component:
HyqVia is a dual-vial therapy. It pairs human immunoglobulin with recombinant human hyaluronidase (an enzyme). The enzyme is infused first to temporarily open up space in the subcutaneous tissue beneath the skin. This allows a much larger volume of immunoglobulin to be absorbed into the bloodstream than traditional subcutaneous (SCIG) therapies. 
2. Administration & Convenience:
IVIG: Administered directly into a vein, typically requiring an intravenous line (or central port) and a visit to an infusion center or hospital. Infusions take 2 to 6 hours. 
HyqVia: Administered subcutaneously using a tiny needle under the skin (usually in the abdomen or thighs). Because of the hyaluronidase, patients can infuse a full month's dose at home in about 2 hours, usually spaced every 3 to 4 weeks (similar to IVIG dosing schedules). 

Is HyqVia More or Less Effective Than IVIG?
In clinical terms, HyqVia and IVIG offer equivalent therapeutic effectiveness.

Comparable Outcomes: Clinical trials comparing HyqVia to traditional IVIG for conditions like Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) demonstrate that HyqVia maintains steady IgG blood levels and protects against infection/relapse just as effectively as IVIG.

Smoother Level Curves: IVIG causes a rapid "spike" in antibody levels immediately after infusion, followed by a noticeable drop-off (trough) before the next monthly dose, which can lead to a "wear-off" effect where patients feel fatigued right before their next appointment. HyqVia is absorbed more gradually from the subcutaneous tissue, resulting in steadier IgG concentration levels over time.

23 hours ago (edited)
A MyMyelomaTeam Member

Is it better than IVIG infusions?

1 day ago
MyMyelomaTeam

HyqVia is a subcutaneous immunoglobulin treatment sometimes used in myeloma to help manage low antibody levels (hypogammaglobulinemia), which can occur as a result of the disease or its treatments. It's given as an under-the-skin infusion, typically at home or in a clinic.

While there aren't specific member experiences Show Full Answer

HyqVia is a subcutaneous immunoglobulin treatment sometimes used in myeloma to help manage low antibody levels (hypogammaglobulinemia), which can occur as a result of the disease or its treatments. It's given as an under-the-skin infusion, typically at home or in a clinic.

While there aren't specific member experiences about HyqVia in the available information right now, subcutaneous injections in general are a common topic among people managing myeloma.

Some general tips shared by MyMyelomaTeam members about subcutaneous injections include:

- Rotating injection sites can help reduce pain and skin reactions
- Topical creams (like clobetasol) have helped some members manage redness or rashes at injection sites
- Letting your care team know about any skin reactions, swelling, or discomfort right away

It's always worth discussing any concerns about injection-site reactions or the infusion process with your oncologist or nurse, as they can offer personalized guidance. Connecting with others on MyMyelomaTeam who may have direct HyqVia experience could also be really valuable!

1 day ago

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Lake Charles, LA

A MyMyelomaTeam Member asked a question 💭
Jacksonville, FL